← Eichor
Condition: Autotransfusion Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Autotransfusion

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis
NA · 1 location(s) · Guangdong Provincial People's Hospital · NCT06244264Chemotherapy Supported by Autologous Hematopoietic Stem Cells
NA · 1 location(s) · Chongqing University Cancer Hospital · NCT05401162Platelet and Autotransfusion Device in Cardiac Surgery
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT06629311Hematopoietic Stem Cell-containing Autologous Blood Reinfusion for Bone Marrow Protection in Cervical Cancer Patients
NA · 1 location(s) · Chongqing University Cancer Hospital · NCT05401175CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/L
NA · 2 location(s) · Zhu Xiaofan · NCT06355739S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion
Phase 1 · 1 location(s) · James Reynolds · NCT03999229Patient Blood Management Charité (PBM-Charité): Structured Detection, Differentiated Diagnostics and Therapy of Preopera
Phase N/A · 1 location(s) · Charite University, Berlin, Germany · NCT05146726COmbined pLaTelet and eRythrocyte AutotransfusioN During Cardiac surgEry (COLTRANE) Trial
NA · 10 location(s) · University Hospital, Bordeaux · NCT06425614
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.